Results 101 to 110 of about 98,536 (126)

Proteasome: Role in T Cell Function Regulation. [PDF]

Int J Biol Sci
Tang D, Wu X, Lei JH, Qiao Y, Deng CX.
europepmc   +1 more source

Building up and breaking down: co-ordination of cell wall production and proteasome assembly. [PDF]

FEBS J
Williams TD.
europepmc   +1 more source

Substrate structure determines p97- and RAD23A/B-mediated proteasomal degradation in human cells. [PDF]

J Biochem
Ding Y, Tomita T, Tsuchiya H, Saeki Y.
europepmc   +1 more source

The COP9 signalosome variants CSNCSN7A and CSNCSN7B form complexes with specific CRLs which are targets of autophagy. [PDF]

Essays Biochem
Dubiel W, Dubiel D.
europepmc   +1 more source

An Integrated Approach of Proteomic, Cheminformatic, and In Vitro Drug Screening to Identify Potential Therapeutic Targets of <i>Taenia solium</i> Cysticerci Proteases. [PDF]

ACS Omega
Kaur R, Rawat SS, Keshri AK, Arora N, Mehra P, Chaudhary A, Sharma S, Kumar R, Mishra A, Prasad A.   +9 more
europepmc   +1 more source

The ubiquitin system targets translocated EspH to proteasomal degradation. [PDF]

Gut Microbes
Nandi I, Zlotkin-Rivkin E, Schoffman H, Aroeti B.   +3 more
europepmc   +1 more source

Human RBM3 protein is prone to form neuronal aggregates opposed by the proteasome. [PDF]

Biol Open
Kumar S, Kleven T, Ciosk R.
europepmc   +1 more source

HBV Infection Drives PSMB5-Dependent Proteasomal Activation in Humanized Mice and HBV-Associated HCC. [PDF]

Viruses
Jannuzzi AT, Sari G, Arslan-Eseryel S, Zeybel M, Yilmaz Y, Dayangac M, Yigit B, Arga KY, Boonstra A, Eren F, Karademir-Yilmaz B.   +10 more
europepmc   +1 more source

Proteasome inhibition as a potential therapeutic target in thymic cancer. [PDF]

Cell Death Dis
Okada S, Benter L, Schrell L, Müller D, Selcen S, Bohnenberger H, Schneider C, Schneider G, Lohrberg M, Koch R, Overbeck TR, von Hammerstein-Equord A, Welter S, Hinterthaner M, Cordes L, Shirneshan K, Netzer C, Inoue M, Marx A, Ströbel P, Küffer S.   +20 more
europepmc   +1 more source